Southbound Funds Net Sold HK$10.4 Billion on August 20, Tracker Fund Dumped Over HK$2.7 Billion
Nashnova编辑部
Southbound capital net sold HK$10.4 billion on August 20, with the Tracker Fund of Hong Kong alone dumped for over HK$2.7 billion — a sign of systematic de-risking from HK equity ETFs; Alibaba bucked the trend with HK$2.2 billion in net buying, but its after-hours earnings missed on profit, clouding the outlook.
HK$10.4 billion in net selling — what is northbound money pulling out of?
Shanghai-linked Stock Connect net sold HK$5.11 billion; Shenzhen-linked net sold HK$5.3 billion — selling pressure split almost evenly.
This means → the retreat is not a single-channel blip but a synchronized pullback from both Shanghai and Shenzhen capital.
The largest single target was the Tracker Fund (02800), dumped for HK$2.76 billion — nearly a quarter of total net selling. In plain terms = mainland money was not selling individual companies; it was selling the index basket — "Hong Kong equities" as a whole.
How do brokerages read this rally?
Industrial Securities said the current HK stock rally is still driven by low-valuation repair, capital rebalancing, and an extreme-sentiment reversal — not yet a broad reversal powered by widespread earnings upgrades.
Huatai Securities added that further valuation gains require two things: AI progress and earnings delivery by HK-listed companies, and stronger domestic-demand policy.
This reflects a shared call: the rally remains valuation-driven, fundamentals have not taken the baton, and large-scale profit-taking by northbound funds has its own logic.
Tencent and SMIC were sold, yet Alibaba was bought — why?
Tencent (00700) saw net selling of HK$408 million; SMIC (00981) saw HK$350 million — two heavyweight names trimmed on the same day.
Alibaba (09988) bucked the trend with net buying of HK$2.205 billion, the single largest northbound buy of the day.
In plain terms = while funds were broadly de-risking HK equities, they placed a concentrated bet on Alibaba — wagering on a short-term expectations gap ahead of after-hours earnings.
Alibaba's after-hours report card — revenue passed, but profit fell short?
Alibaba's FY2027 Q1 revenue came in at RMB 268.95 billion, up 9% year-on-year, slightly beating the consensus estimate of RMB 268.52 billion.
Adjusted net income, however, was RMB 20.72 billion — below the RMB 25.58 billion estimate. Adjusted earnings per ADS were RMB 8.52, versus an expected RMB 11.28.
Capital expenditure for the quarter reached RMB 67.68 billion, up 75% year-on-year. This means → the profit squeeze was driven mainly by heavy AI-infrastructure spending; top-line growth is healthy, but short-term profitability was eaten by capex.
Kuaishou drew HK$1.1 billion in buying — is Kling AI the key?
Kuaishou (01024) attracted net buying of HK$1.143 billion.
Its earnings showed that Kling AI — Kuaishou's AI video-generation product — posted Q2 revenue above RMB 850 million, up over 200% year-on-year and 30.8% quarter-on-quarter. Core commercial revenue rose 7.4% year-on-year to RMB 26.845 billion.
This means → the buying logic mirrors Alibaba's — a bet on AI monetization — but Kuaishou's Kling AI has already produced a high-growth revenue curve, making the thesis more concrete.
Why did pharma stocks split into "fire and ice"?
GenScript Biotech (01548) drew net buying of HK$205 million; WuXi Biologics (02269) drew HK$91.83 million. But CSPC Pharmaceutical (01093) was net sold by HK$1.091 billion.
The catalyst: on August 19, Moderna and Merck reported that their personalized mRNA cancer vaccine — a vaccine custom-built for each patient — combined with Keytruda met its endpoint in a Phase III melanoma interim analysis.
In plain terms = an overseas mRNA vaccine clears a key clinical hurdle → upstream raw-material and contract-manufacturing demand is set to grow → that benefits CRO/CDMO firms (drug-development and manufacturing outsourcing companies) like GenScript and WuXi Biologics. For CSPC, which relies on in-house drug development, the competitive landscape gets tougher — hence funds moved in opposite directions.
Content is for reference only, not financial advice.